She doesn't like to be called out?
Black Fathers Matter
It's so obvious it's become comical.
Rules For Radicals can help Patriots fight the cabal.
RULE 5: “Ridicule is man’s most potent weapon.”
There is no defense. It’s irrational. It’s infuriating. It also works as a key pressure point to force the enemy into concessions.
https://bolenreport.com/saul-alinskys-12-rules-radicals/
Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH
Saturday, June 13, 2020 11:30 AM EDT
ACCESSWIRE is pleased to announce the appointment of Roger C. Clinton, to the Advisory Board for its wholly owned subsidiary, Verrian GmbH. Clinton is active within the addiction treatment and specifically opiate addiction research sector, seeking to bring attention to the issue and enhance promising treatment options using psychedelics in conjunction with behavioral therapy through his global network.
"I'm honored to be working with the team at Mota in a patient first approach. We believe the work that we're doing can be transformative in people's lives as they work daily to overcome addiction," said Roger Clinton.
On June 2nd, Mota announced the $20,000,000 acquisition of Verrian, a European pharmaceutical manufacturer of natural psilocybin extracts.Verrian is focused on psychedelic and cannabis treatments of opiate addiction. Clinton will play a vital role in advising and enhancing the patient perspective as well as helping to shape R&D efforts of our world-renowned addiction medicine experts, resulting in best of breed psychedelic derived treatments for the global marketplace.
Ryan Hoggan, Chief Executive Officer, stated "We're honored to be working with Roger, an advocate for patient first treatment options. Roger's work in advocacy for opiate addiction research will enhance MOTA's research efforts and help to draw attention to our ground-breaking psychedelic research we as we jointly seek new treatments to help patients overcome addiction."
ABOUT ROGER
Roger Cassidy Clinton is a true multi-hyphenate: singer-songwriter, voice-over artist, actor, author, up-close political observer (quite the understatement) and, arguably, one of the world's biggest sports enthusiasts. He is also a living, inspiring story of recovery.
Roger, President Bill Clinton's younger brother, is blessed with a spectacular group of friends from all walks of life, including the "who's who" in the world of music, entertainment, sports (collegiate and professional) and, of course, politics. Working, associating and performing with people who have attained the highest levels of success in their professions has enabled Roger to forge priceless relationships that will last a lifetime. These relationships have brought him many unique, exciting experiences with more than a few once-in-a-lifetime opportunities.
Throughout it all, however, Roger has struggled with decades of alcohol and substance abuse that at one point left him clinically dead. Miraculously, medical personnel were able to revive Roger, and he improbably averted tragedy and survived. Through his personal, ongoing journey of recovery from a life complicated by addiction and trauma, Roger is grateful to have gained profound insight that he is privileged to share in order to help spread light and optimism with the world.
https://www.accesswire.com/593771/Mota-Ventures-Appoints-Roger-C-Clinton-as-Member-of-Advisory-Board-to-Verrian-GmbH
Huge therapeutic potential
Potential Therapeutic Effects of Psilocybin
Neurotherapeutics 2017 Jul;14(3):734-740. doi: 10.1007/s13311-017-0542-y.
Abstract
Psilocybin and other 5-hydroxytryptamine2A agonist classic psychedelics have been used for centuries as sacraments within indigenous cultures. In the mid-twentieth century they were a focus within psychiatry as both probes of brain function and experimental therapeutics. By the late 1960s and early 1970s these scientific inquires fell out of favor because classic psychedelics were being used outside of medical research and in association with the emerging counter culture. However, in the twenty-first century, scientific interest in classic psychedelics has returned and grown as a result of several promising studies, validating earlier research. Here, we review therapeutic research on psilocybin, the classic psychedelic that has been the focus of most recent research. For mood and anxiety disorders, three controlled trials have suggested that psilocybin may decrease symptoms of depression and anxiety in the context of cancer-related psychiatric distress for at least 6 months following a single acute administration. A small, open-label study in patients with treatment-resistant depression showed reductions in depression and anxiety symptoms 3 months after two acute doses. For addiction, small, open-label pilot studies have shown promising success rates for both tobacco and alcohol addiction. Safety data from these various trials, which involve careful screening, preparation, monitoring, and follow-up, indicate the absence of severe drug-related adverse reactions. Modest drug-related adverse effects at the time of medication administration are readily managed. US federal funding has yet to support therapeutic psilocybin research, although such support will be important to thoroughly investigate efficacy, safety, and therapeutic mechanisms.
https://pubmed.ncbi.nlm.nih.gov/28585222/?from_term=psilocybin&from_pos=4
those digits anon!
mushrooms helped my son as well
was skeptical but hard to deny the success
Well the Clintons certainly want a piece of the action.
Why does MSDNC have the body cam footage?
When the people awaken, game over.
The rioters beat up a CNN crew in Atlanta while watching Wendy's burn?
Karma is funny in a karma kinda way.
never run out of microwave nuggets
po po need big fishing nets
>Newt takes a shit on the wealth transfer plan of the D Party Cons.
Kek based baker summary!
shoulda built better borders to keep out the undesirables.